Erratum To: A 2-Year Observational Study of Patients with Relapsing-Remitting Multiple Sclerosis Converting to Glatiramer Acetate from Other Disease-Modifying Therapies: the Coptimize Trial (J Neurol, (2014), 261, (2101-2111), 10.1007/S00415-014-7446-0)

AuthID
P-00K-66C
14
Author(s)
Carrá, A
·
de Klippel, N
·
Correia de Sá, J
·
Edland, A
·
Frederiksen, JL
·
Heinzlef, O
·
Karageorgiou, KE
·
Lander Delgado, RH
·
Macías Islas, MA
·
Tubridy, N
·
Gilgun Sherki, Y
Document Type
Correction
Year published
2015
Published
in Journal of Neurology, ISSN: 0340-5354
Volume: 262, Issue: 1, Pages: 248
Indexing
Publication Identifiers
Scopus: 2-s2.0-84957940498
Source Identifiers
ISSN: 0340-5354
Export Publication Metadata
Marked List
Info
At this moment we don't have any links to full text documens.